Systemic Thrombolysis as Initial Treatment of COVID-19 Associated Acute Aortoiliac and Lower Extremity Arterial Thrombosis.
Ann Vasc Surg
; 70: 297-301, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-733967
ABSTRACT
SARS-CoV-2 (COVID-19) patients with associated thromboembolic events have demonstrated poor outcomes despite the use of anticoagulation therapy and surgical intervention. We present a COVID-19 patient with acute limb ischemia, secondary to extensive thrombosis of an aortic aneurysm, iliac arteries, and infrainguinal arteries. Initial treatment with systemic thrombolysis, which restored patency of the aortoiliac occlusion, was followed by open thrombectomies of the infrainguinal occlusions.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Arterial Occlusive Diseases
/
Thrombosis
/
Thrombolytic Therapy
/
Tissue Plasminogen Activator
/
Aortic Aneurysm, Abdominal
/
Fibrinolytic Agents
/
COVID-19
/
Iliac Artery
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Aged
/
Humans
/
Male
Language:
English
Journal:
Ann Vasc Surg
Journal subject:
Vascular Diseases
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS